Table 7.
Group | Control | NC | MiR-21 mimics | MiR-21 inhibitors | MiR-21 mimics + lenti PTEN | MiR-21 mimics + VEGF siRNA |
---|---|---|---|---|---|---|
miR-21 | 1.00±0.06 | 1.02±0.10 | 3.98±0.59*# | 0.25±0.05*#@ | 3.88±0.57*#& | 3.93±0.62*#& |
PTEN | 1.00±0.06 | 1.03±0.09 | 0.39±0.10*# | 1.96±0.24*#@ | 0.79±0.07*#@& | 0.42±0.11*#&^ |
VEGF | 1.00±0.07 | 0.98±0.08 | 2.12±0.33*# | 0.38±0.09*#@ | 1.53±0.14*#@& | 1.42±0.17*#@& |
P<0.05 versus control group;
P<0.05 versus NC group;
P<0.05 versus miR-21 mimics group;
P<0.05 versus miR-21 inhibitors group;
P<0.05 versus miR-21 mimics + lenti PTEN group.